Organic Active Ingredients TRIZ Cases

Molecular glue compounds bridge cereblon and CDK2 to induce targeted protein ubiquitination, solving inadequate specificity in existing cancer therapies.

Sanguinarine elevates reactive oxygen species to degrade EGFR, overcoming steric hindrance from the T790M mutation.

Anti-microRNA compositions upregulate TULA-2 to inhibit platelet activation, avoiding serious bleeding risks associated with conventional thrombosis treatments.

Coexisting stabilizers suppress diclofenac lactam generation in hyaluronic acid compositions, preserving therapeutic efficacy during storage.

Recombinant vectors express cancer antigens for non-invasive detection, resolving the trade-off between diagnostic sensitivity and procedural complexity.

Transient Runx1-CBFβ inhibitor treatment induces hematopoietic stem cell specification from progenitor cells.

Formula I compounds competitively bind the EGFR kinase ATP site, inhibiting proliferation of cells resistant to first-line therapies like erlotinib.

Incorporating 1% to 4.5% (R)-nicotine into aerosol formulations reduces throat irritation and improves sensory effects without altering manufacturing processes.

Chewing gum composition delivers cannabinoids via oral mucosa absorption, eliminating respiratory harm from combustion.

Antisense oligonucleotides induce exon skipping in immunoglobulin transcripts, producing truncated proteins that trigger apoptosis in cancerous plasma cells.

Azaindazole compounds antagonize Wnt pathway activity to treat cancers and fibrotic disorders caused by aberrant signaling.

Subcutaneous triamcinolone injection induces targeted fat cell atrophy, avoiding surgical risks and systemic side effects.

Co-solvent evaporation with surface-active excipients resolves poor aerosolization by mediating water-insoluble active agent dispersion.

Dissolving active agents in liquid vehicles inside soft gel capsules improves bioavailability while reducing side effects from high-dose administration.

Needle-free intranasal naloxone delivery eliminates injection risks while achieving reliable blood levels through optimized pH formulation.

A flurbiprofen orally-disintegrating tablet formulation uses a graft copolymer to achieve rapid disintegration.

Irreversible acrylamide warheads on quinazoline cores overcome T790M drug resistance by blocking EGFR signal transduction.

Replacing gelatin with polysaccharide derivatives eliminates heat sensitivity while the hygroscopic solvent maintains moisture balance for stable drug delivery.

CB2 receptor antagonists reverse endocannabinoid-induced T cell suppression, restoring antitumor immune responses and inhibiting cancer cell proliferation.

Segmented genetic circuits use universal regulatory elements to resolve the trade-off between detection sensitivity and structural complexity.

Spray-dried ibrutinib solid dispersions disperse the drug in a polymer matrix, reducing pharmacokinetic variability compared to traditional capsules.

Antioxidant-stabilized micronized granules preserve Syk/JAK inhibitor purity during open container storage.

Truncated RNA aptamers inhibit NGF receptor binding without triggering immune reactions associated with antibody therapies.

Imidazopyrazine compounds inhibit Syk enzymatic activity, reducing B-cell activation and side effects in autoimmune diseases.

Sulphamoylpyrrolamide derivatives inhibit hepatitis B virus replication while reducing toxicity and improving bioavailability compared to existing antivirals.

Self-assembled rosette nanotubes protect small RNA from serum degradation while enabling efficient cellular uptake through endocytosis.

Specific 2-hydroxy-1-{4-[(4-phenylphenyl)carbonyl]piperazin-1-yl}ethan-1-one derivatives inhibit fatty acid synthase activity.

Heterocyclic compounds inhibit JAK1 kinase activity through specific molecular binding, reducing toxicity from non-selective inhibition.

3-substituted amino-2-arylpyrrolo[2,3-c]pyridine compounds overcome drug resistance in cancer cells by inhibiting protein kinase CK2.

Antisense oligonucleotides hybridize to utrophin mRNA binding sites to boost protein levels in muscle cells.

Anti-IL-5 antibodies achieve defined plasma concentrations to suppress eosinophil production, avoiding corticosteroid side effects.

N2-modified guanine bases stabilize G-quadruplex nanoparticles, resolving the contradiction between structural integrity and functional versatility.

Water-soluble prodrug and enzyme system bypasses solubility limits, enabling rapid intranasal absorption without organic excipients.

A self-nanoemulsifying formulation disperses poorly soluble drugs into nanoemulsions upon aqueous exposure.

A tissue culture media matrix supports human pancreatic islet survival and engraftment.

Galactose increases serpin production in Bifidobacterium longum to treat celiac disease without GMO regulatory hurdles.

Computational docking optimizes substituted imidazopyridines to inhibit ENPP1, resolving the trade-off between treatment efficacy and adverse side effects.

Liposomes in a continuous hydrophobic phase deliver antigens to induce long-lasting cytotoxic T lymphocyte responses, preventing tumor recurrence.

Carrier-free nanoparticles stabilized with a native albumin layer provide improved circulation stability and targeted cell interaction.

A polyethylene glycol conjugate with local anesthetics creates a sustained release system for extended pain relief.

Arginine and antioxidants stabilize pemetrexed in liquid form, preventing oxidative degradation without freeze drying.

FR-targeting agents deliver antigens to first responder dendritic cells using TLR agonists, resolving low targeting precision in vaccine development.

Neoandrographolide lowers blood glucose and lipid levels while protecting liver and renal function in a single pharmaceutical composition.

A plant extract containing concentrated diketopiperazines forms through thermal processing of protein sources.